Outcomes in Patients Receiving Treatment for Pulmonary Arterial Hypertension Associated With Repaired Congenital Heart Disease

By sjmartinez • February 26, 2025

Krasuski RA, Tobore T, Studer S, Jansa P, Sitbon O, Hoeper MM, Channick R, Gaine S, Lang I, Chin K, Pulido T, Mehta S, Torbicki A, Sastry B, Tang X, McLaughlin V, Reardon LC. Outcomes in Patients Receiving Treatment for Pulmonary Arterial Hypertension Associated With Repaired Congenital Heart Disease. JACC Adv. 2025 Feb 24;4(3):101626. doi: 10.1016/j.jacadv.2025.101626. Epub ahead of print. PMID: 39999520.

Tags: Cardiology/Epi, COMPASS-2, congenital heart disease, GRIPHON, Pooled analysis, Publications, pulmonary arterial hypertension, Pulmonary, Critical Care & Sleep Medicine, SERAPHIN

CT Emphysema Subtypes and Cardiac Hemodynamics Estimated on Magnetic Resonance Imaging: The MESA COPD Study

Hermann EA, Yang JX, Angelini E, Balte P, Bluemke DA, Carr J, Derlin K, Gomes AS, Habibi M, Hoffman EA, Johns C, Kawut SM, Kiely[...]

Quantitative approaches to 18F-flurpiridaz positron emission tomography image analysis

Packard RRS, deKemp RA, Knuuti J, Moody JB, Renaud JM, Saraste A, Slomka PJ. Quantitative approaches to 18F-flurpiridaz positron emission tomography image analysis. J Nucl Cardiol.[...]

Alcohol Exposure Among Patients With Dilated Cardiomyopathy and Their First-Degree Relatives: The DCM Precision Medicine Study

Jimenez J, Ni H, Katz SD, Haas GJ, Cao J, Rubens M, Chaparro S, Saxena A, Hofmeyer M, Kransdorf E, Ewald GA, Morris AA, Owens[...]